GSK
NYSE GSK plc Sponsored ADR$46.36 ↓ -0.66 (-1.40%) Trading Down from the previous close of $47.02
- YTD change
- -5.46%
- vs 20-day SMA
- -5.38%
- vs 200-day SMA
- -11.51%
Price ranges
Price & Performance
-10.35 (-18.04%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 24.9% away from all-time highs of $61.70
- GSK is down 5% since the beginning of the year
- GSK is up 7% over the past 12 months
- GSK is down 5% over the past 1 month
- 1% of all GSK investors are betting against GSK
- Number of investors short GSK has gone up 8% versus last month
GSK reads poor: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +8.5%.
- Previous minute
- -$0.02
- Last hour
- -$0.13
- Last 5 days
- -3.76%
- vs 8-day SMA
- -2.81%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
